• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素疗法对绝经后女性免疫标志物的影响。

Influence of estrogen therapy on immune markers in postmenopausal women.

作者信息

Itaborahy R M Ribeiro, de Medeiros S Freitas

机构信息

a Federal University of Mato Grosso, School of Medicine , Department of Obstetrics and Gynecology , Cuiabá , Brazil.

出版信息

Climacteric. 2016 Oct;19(5):496-500. doi: 10.1080/13697137.2016.1212828. Epub 2016 Sep 3.

DOI:10.1080/13697137.2016.1212828
PMID:27593223
Abstract

OBJECTIVE

To evaluate the impact of estrogen therapy on cellular and humoral immune markers in postmenopausal women.

METHODS

This prospective, controlled cohort study included 30 patients who used oral estradiol (1 mg) for 14-17 weeks and 28 patients who served as controls. Total leukocytes and leukocyte subtypes were counted and immunophenotyped by flow cytometry. The concentrations of immunoglobulins and pro- and anti-inflammatory cytokines were also measured in the peripheral blood before and after estrogen therapy. Immunoglobulin E level was measured by electrochemiluminescence, and levels of immunoglobulins A, G, and M were measured by nephelometry. Simultaneous quantification of multiple cytokines was performed by chemiluminescence to measure the serum concentrations of interferon gamma, interleukin (IL)-4, IL-6, IL-10, and IL-17.

RESULTS

Hematological cellular components were not significantly different before and after the use of estradiol (p = 0.332-0.984). Serum concentrations of immunoglobulins G, M, E, and A also remained stable (p = 0.248-0.845). Finally, cytokines were not modified throughout the 14-17 weeks of follow-up (p = 0.407-0.873).

CONCLUSION

Isolated estrogen therapy with 1 mg of estradiol for 14-17 weeks in postmenopausal women did not modify any of the cellular or humoral immune markers analyzed in this study.

摘要

目的

评估雌激素治疗对绝经后女性细胞免疫和体液免疫标志物的影响。

方法

这项前瞻性对照队列研究纳入了30例口服雌二醇(1毫克)14 - 17周的患者和28例作为对照的患者。通过流式细胞术对全血细胞和白细胞亚型进行计数及免疫表型分析。在雌激素治疗前后还对外周血中的免疫球蛋白、促炎和抗炎细胞因子浓度进行了检测。免疫球蛋白E水平通过电化学发光法测定,免疫球蛋白A、G和M水平通过散射比浊法测定。通过化学发光法同时对多种细胞因子进行定量,以测量血清中干扰素γ、白细胞介素(IL)-4、IL-6、IL-10和IL-17的浓度。

结果

使用雌二醇前后血液学细胞成分无显著差异(p = 0.332 - 0.984)。免疫球蛋白G、M、E和A的血清浓度也保持稳定(p = 0.248 - 0.845)。最后,在14 - 17周的随访期间细胞因子未发生改变(p = 0.407 - 0.873)。

结论

绝经后女性单独使用1毫克雌二醇进行14 - 17周的雌激素治疗,并未改变本研究中分析的任何细胞免疫或体液免疫标志物。

相似文献

1
Influence of estrogen therapy on immune markers in postmenopausal women.雌激素疗法对绝经后女性免疫标志物的影响。
Climacteric. 2016 Oct;19(5):496-500. doi: 10.1080/13697137.2016.1212828. Epub 2016 Sep 3.
2
Cellular and humoral immune responses after short-term oral hormone therapy in postmenopausal women.绝经后妇女短期口服激素治疗后的细胞和体液免疫反应。
Climacteric. 2011 Dec;14(6):677-82. doi: 10.3109/13697137.2011.570387. Epub 2011 Oct 10.
3
Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study.
Am J Reprod Immunol. 2002 Aug;48(2):63-9. doi: 10.1034/j.1600-0897.2002.01061.x.
4
Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.绝经后女性雌激素治疗对外周血中细胞因子的影响。
J Bone Miner Res. 1998 Oct;13(10):1577-86. doi: 10.1359/jbmr.1998.13.10.1577.
5
Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.激素替代疗法对绝经后女性血浆促炎和抗炎细胞因子及一些骨转换标志物的影响。
Pharmacol Res. 2006 Oct;54(4):298-302. doi: 10.1016/j.phrs.2006.06.006. Epub 2006 Jun 30.
6
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.替勃龙、经皮雌二醇或口服雌激素 - 孕激素疗法:对循环中别孕烯醇酮、皮质醇和脱氢表雄酮水平的影响。
Gynecol Endocrinol. 2005 Mar;20(3):144-9. doi: 10.1080/09513590400021169.
7
Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy.
Menopause. 2001 Jul-Aug;8(4):266-73. doi: 10.1097/00042192-200107000-00008.
8
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.复合生物等效透皮激素疗法对围绝经期和绝经后女性的止血、炎症、免疫因子、心血管生物标志物、生活质量指标及健康结局的影响。
Int J Pharm Compd. 2013 Jan-Feb;17(1):74-85.
9
Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.口服共轭雌激素和经皮雌二醇对绝经后女性动脉僵硬度和血管炎症标志物的不同影响。
Atherosclerosis. 2006 Dec;189(2):436-42. doi: 10.1016/j.atherosclerosis.2005.12.030. Epub 2006 Feb 15.
10
Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.口服和经皮雌激素疗法对子宫切除术后绝经后女性循环细胞因子和趋化因子的影响。
Eur J Endocrinol. 2009 Aug;161(2):267-73. doi: 10.1530/EJE-09-0063. Epub 2009 May 18.